«

»

Aug 29

European societies have published a joint consensus statement on antithrombotic therapy in patients with nonvalvular atrial fibrillation (AF)

European societies have published a joint consensus statement on antithrombotic therapy in patients with nonvalvular atrial fibrillation (AF) who present with an acute coronary syndrome (ACS) and may undergo PCI. The statement provides updates since the advent of new oral anticoagulant (NOAC) agents and “new–generation” drug–eluting stents (DES) and also addresses antithrombotic therapy in AF patients undergoing transcatheter aortic–valve implantation (TAVI). The document was published August 25 in the European Heart Journal.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>